Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.7 - $1.56 $13,229 - $29,482
-18,899 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$1.37 - $2.43 $6,729 - $11,936
-4,912 Reduced 20.63%
18,899 $26,000
Q3 2021

Nov 15, 2021

SELL
$3.37 - $4.76 $125,697 - $177,543
-37,299 Reduced 61.04%
23,811 $99,000
Q2 2021

Aug 16, 2021

BUY
$4.75 - $9.39 $290,272 - $573,822
61,110 New
61,110 $290,000

Others Institutions Holding ONCT

About Oncternal Therapeutics, Inc.


  • Ticker ONCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,517,200
  • Market Cap $63.3M
  • Description
  • Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...
More about ONCT
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.